Paladin Labs Inc.: Canadian Women To Be Granted Easier Access To Emergency Contraception

Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that the National Drug Scheduling Advisory Committee (NDSAC) has recommended Paladin’s application to move Plan B® from Behind-the-Counter status to full Over-the-Counter (OTC) status to the National Association of Pharmacy Regulatory Authorities (NAPRA).

More: continued here

Filed under: Women's Health / OBGYN on April 17th, 2008